260391-65-9Relevant articles and documents
Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPT
Sagnou, Marina J.,Howard, Philip W.,Gregson, Stephen J.,Eno-Amooquaye, Ebun,Burke, Philip J.,Thurston, David E.
, p. 2083 - 2086 (2007/10/03)
Three N10-(4-nitrobenzyl)carbamate-protected PBD prodrugs (9a, 9b and 15) have been synthesized and evaluated for potential use in nitroreductase-based ADEPT and GDEPT therapies. An approximately 100-fold activation was observed for the DC-81 prodrug 9a.